Falsely prolonged activated partial thromboplastin time - a pre- and post-analytical issue

Charlotte Gils, Pernille Just Vinholt, Mads Nybo, Charlotte Gils, Pernille Just Vinholt, Mads Nybo

Abstract

This case highlights two common pre-analytical problems identified in routine coagulation testing of activated partial thromboplastin time (aPTT), which were overlooked because of a concurrent flag code indicating no coagulation and the result was replaced by asterisks. It concerns a boy with gastrointestinal bleeding and prolonged aPTT > 300 seconds, which raised the suspicion of haemophilia. When all other coagulation parameters (including specific coagulation factors VIII and IX) turned out to be normal, aPTT was re-measured using another analysis principle, which revealed a normal aPTT. The primary aPTT result turned out to be aborted due to concurrent haemolysis and lipaemia, but was erroneously interpreted as prolonged coagulation. The lesson is awareness of the possibility of numerous flag codes on the same sample overruling each other, and awareness on the responsibility in the post-analytical phase that must be carried by increased educational focus and by the manufacturers.

Keywords: activated partial thromboplastin time; haemolysis; lipemia; post-analytical errors; pre-analytical errors.

Conflict of interest statement

Potential conflict of interest: None declared.

Figures

Figure 1
Figure 1
The aPTT measurement curve in the patient sample. X-axis: time (s), Y-axis: aPTT-value (s). aPTT - activated partial thromboplastin time.
Figure 2
Figure 2
A normal aPTT measurement curve. aPTT - activated partial thromboplastin time.

References

    1. Lippi G, Plebani M, Favaloro JE. Interference in Coagulation Testing: Focus on Spurious Hemolysis, Icterus, and Lipemia. Semin Thromb Hemost. 2013;39:258–66.
    1. Lippi G, Blanckaert N, Bonini P, Green S, Kitchen S, Palicka V, et al. Haemolysis: an overview of the leading cause of unsuitable specimens in clinical laboratories. Clin Chem Lab Med. 2008;46:764–72. 10.1515/CCLM.2008.170
    1. Clinical and Laboratory Standards Institute (CLSI). Collection, transport, and processing of blood specimens for testing plasma-based coagulation assays and molecular hemostasis assays. Approved Guideline - Fifth edition. CLSI document H21-A5. Wayne, USA: CLSI, 2008.
    1. Falay M, Senes M, Yücel D, Turhan T, Dagdas S, Pekin M, et al. What should be the laboratory approach against isolated prolonged activated partial thromboplastin time? J Clin Lab Anal. 2018;e22415:•••.; epub ahead of print 10.1002/jcla.22415
    1. Geens T, Vertessen F, Malfait R, Deiteren K, Maes MB. Validation of the Sysmex CS5100 coagulation analyzer and comparison to the Stago STA-R analyzer for routine coagulation parameters. Int J Lab Hematol. 2015;37:372–81. 10.1111/ijlh.12295
    1. Lippi G, Plebani M, Favaloro EJ. Interference in coagulation testing: focus on spurious hemolysis, icterus, and lipemia. Semin Thromb Hemost. 2013;39:258–66.
    1. Favaloro EJ, Lippi G. Hemostasis and Thrombosis, Methods and Protocols. Methods in Molecular Biology. Springer Science 2017, pp. 545-58.
    1. Hensch L, Kostousov V, Bruzdoski K, Losos M, Pereira M, de Guzman M, et al. Does rotational thromboelastometry accurately predict coagulation status in patients with lupus anticoagulant? Int J Lab Hematol. 2018;•••:1–6. 10.1111/ijlh.12852
    1. Tantanate C, Teyateeti M, Tientadakul P. Influence of plasma interferences on screening coagulogram and performance evaluation of the automated coagulation analyzer Sysmex CS-2100i. Siriraj Med J. 2011;63:151–6.
    1. Laga AC, Cheves TA, Sweeney JD. The effect of specimen hemolysis on coagulation test results. Am J Clin Pathol. 2006;126:748–55. 10.1309/03FK3378YTRA1FRF
    1. Lippi G, Montagnana M, Salvagno GL, Guidi GC. Interference of blood cell lysis on routine coagulation testing. Arch Pathol Lab Med. 2006;130:181–4.
    1. Quehenberger P, Kapiotis S, Handler S, Ruzicka K, Speiser W. Evaluation of the automated coagulation analyzer SYSMEX CA 6000. Thromb Res. 1999;96:65–71. 10.1016/S0049-3848(99)00069-9
    1. Bai B, Christie DJ, Gorman RT, Wu JR. Comparison of optical and mechanical clot detection for routine coagulation testing in a large volume clinical laboratory. Blood Coagul Fibrinolysis. 2008;19:569–76. 10.1097/MBC.0b013e3283070872
    1. Cadamuro J, Mrazek C, Haschke-Becher E, Sandberg S. To report or not to report: a proposal on how to deal with altered test results in hemolytic samples. Clin Chem Lab Med. 2017;55:1109–11. 10.1515/cclm-2016-1064

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj